Erdkamp F, Houben M, Ackerman E, Breed W, van Spreeuwel J
Department of Internal Medicine, Catharina Hospital, Eindhoven, Netherlands.
Neth J Med. 1992 Aug;41(1-2):71-3.
Sulphasalazine is an active agent in the treatment of chronic inflammatory bowel disease, but there are a number of well-known side effects, including pancreatitis. The newer 5-ASA agents are thought to be equally effective but less toxic. Here we describe a patient who developed a pancreatitis due to mesalamine; this was confirmed at rechallenge.
柳氮磺胺吡啶是治疗慢性炎症性肠病的一种活性剂,但有许多众所周知的副作用,包括胰腺炎。新型5-氨基水杨酸制剂被认为同样有效但毒性较小。在此我们描述一名因美沙拉嗪引发胰腺炎的患者;再次激发试验证实了这一点。